«

»

Feb 06

Synthetic cannabis drug trial results in hospitalization and death

Pharmaceutical companies have been trying to manufacture synthetic versions of cannabis for years. Recently, a Portuguese company named Bial produced a drug designed to treat anxiety and pain by blocking process by which the human body breaks down naturally-occurring cannabinoid compounds in the body. Biotrial, a French research organization, conducted the trial of the drug at its facilities in Rennes, France. So far, this resulted in one death and the hospitalization of five other participants.Instead of embracing natural, plant-based medicine that can help a variety of conditions, pharmaceutical companies seem to be hell-bent on creating fake, synthetic versions of cannabis. Why would they do this when cannabis is non-toxic and effective? Why are research funds not poured into testing dosages and the effects of medical marijuana?The answer is money, of course. Unable to make the massive profits they would like to from natural medicines, these companies resort to attempting to imitate nature by conjuring up drugs that are not nearly as effective and are actually dangerous to humans.

Source: Synthetic cannabis drug trial results in hospitalization and death